Contact Us
Drug Search Results
Using advanced filters...
Advanced Search [+]

Propiverine

Alternative Names: propiverine, mictonetten
Latest Update: 2024-02-21
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: MR Antagonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Austria | Belgium | Canada | Croatia | Czech | Egypt | Germany | Greece | Hong Kong | Indonesia | Ireland | Italy | Korea | Lebanon | Malaysia | Mexico | Pakistan | Peru | Philippines | Portugal | Singapore | Slovakia | Slovenia | South Africa | Spain | Switzerland | Taiwan | Thailand | Turkey | United Arab Emirates | United Kingdom | Venezuela

Approved Indications: None

Known Adverse Events: None

Company: APOGEPHA Arzneimittel
Company Location:
Company CEO:
Additional Commercial Interests: None

Clinical Description

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 4: Overactive Bladder|Urinary Incontinence

Phase 3: Overactive Bladder|Urinary Incontinence|Enuresis|Prostatic Hyperplasia|Lower Urinary Tract Symptoms|Urinary Bladder, Neurogenic|Urinary Incontinence, Urge|Urinary Bladder Diseases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
178-MA-3146

N/A

Completed

Overactive Bladder

2020-03-30

178-MA-3147

N/A

Completed

Overactive Bladder

2019-09-13

IF

N/A

Completed

Cystitis, Interstitial

2019-01-01

FRESH

N/A

Completed

Urinary Incontinence, Stress|Enuresis

2015-06-01

Recent News Events

Date

Type

Title

02/21/2024

PubMed

 Risks of Dementia After Treatment with an Anticholinergic, Beta-3 Agonist, or Combination of Both for an Overactive Bladder: A Korean National Cohort Study.

01/15/2024

PubMed

 Predicting muscarinic receptor occupancy in human bladder mucosa from urinary concentrations of antimuscarinic agents for overactive bladder.

12/01/2023

PubMed

 Functional characterization of three G protein-coupled acetylcholine receptors in parasitic nematode Trichinella spiralis.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you've used PRYZM, we hope you're able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions